Yes, shRNA holds potential as a therapeutic approach in cancer treatment. By silencing genes essential for cancer cell survival and proliferation, shRNA can selectively target and kill cancer cells while sparing normal cells. For instance, shRNA targeting the BCL2 gene, which is involved in cell survival, has been explored as a treatment for certain types of leukemia and lymphoma.
